Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia
Conditions: Parkinson Disease; Dyskinesia, Medication-Induced Interventions: Drug: CPL500036 - low dose; Drug: CPL500036 - high dose; Drug: Placebo Sponsors: Celon Pharma SA; National Center for Research and Development, Poland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2022 Category: Research Source Type: clinical trials
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
Condition: Primary Ciliary Dyskinesia Intervention: Sponsor: Arkansas Children's Hospital Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials